{"id":"W1930986821","doi":"10.1155/2001/490921","title":"Infliximab for the Treatment of Crohn'S Disease: Review and Indications for Clinical Use in Canada","year":2001,"lang":"en","type":"review","venue":"Canadian Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Infliximab; Azathioprine; Crohn's disease; Internal medicine; Adverse effect; Ulcerative colitis; Prednisone; Abdominal pain; Gastroenterology; Inflammatory bowel disease; Nausea; Disease; Surgery","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001342371,0.0007339778,0.001783033,0.004822169,0.0005822351,0.001710846,0.001298893,0.001705799,0.01101025],"category_scores_gemma":[0.002688407,0.0003494573,0.001108327,0.006309122,0.0009743859,0.001347174,0.0007939689,0.001813122,0.00320273],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002447881,"about_ca_system_score_gemma":0.006677161,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02133015,"about_ca_topic_score_gemma":0.06167444,"domain_scores_codex":[0.9992871,0.0001119492,0.000190385,0.00007042578,0.0002778422,0.00006246768],"domain_scores_gemma":[0.9974346,0.000707628,0.0006102048,0.00004356513,0.0009107803,0.0002931969],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000323824,0.00007317352,0.0004382634,0.04200438,0.0001409306,0.0003692139,0.0001020722,0.0001416233,0.0008810234,0.001130206,0.0649595,0.8894358],"study_design_scores_gemma":[0.0002295627,0.0001802689,0.003138632,0.0335401,0.0004364394,0.002125587,0.0001134656,0.00008018157,0.0001975153,0.000408328,0.959518,0.00003195339],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001242055,0.9974391,0.00004195201,0.0005116081,0.0002349764,0.0000151785,0.00004481174,0.000006569331,0.0015815],"genre_scores_gemma":[0.0008562192,0.9975839,0.0001540436,0.0004615526,0.0001911283,0.00001311626,0.00006931285,0.000003742321,0.0006669587],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9786699,"threshold_uncertainty_score":0.04241198,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04728925970940304,"score_gpt":0.3301204109052974,"score_spread":0.2828311511958943,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}